Abstract:We read with interest the paper by Altintop et al [1] describing the effect of hemoperfusion in acute anticholinesterase pesticide poisoning. This retrospective uncontrolled study describes a series of patients treated with extracorporeal blood purification. Clinical criteria were used to classify the severity of poisoning of eligible patients, and all patients with severe poisoning were treated with a single 3-hour session of hemoperfusion. We are also interested in the effect of hemoperfusion, and other extracorporeal techniques for blood purification, in the treatment of acute organophosphorus (OP) poisoning. This has prompted us to conduct a systematic review with the Cochrane Collaboration (protocol submitted) [2] to confirm whether further studies were needed and to obtain information to assist us to plan such a study. In that regard, we think it is worth explaining why we believe that this study’s outcomes are insufficient evidence of the benefit of hemoperfusion for this poisoning. The authors’ main outcome was changes in “plasma acetylcholinesterase.” This terminology may potentially mislead some readers. It seems certain from their previous publications, and the units reported in this paper, that this term refers to butyrylcholinesterase (BuChE, pseudocholinesterase, plasma cholinesterase or PChE; EC 3.1.1.8) [3]. In contrast, acetylcholinesterase (AChE; EC 3.1.1.7) is not found in human plasma (only erythrocytes) and is homologous with that found in the nervous system. Inhibition of synaptic AChE appears to be the primary toxicity from OP pesticides. A large increase in BuChE activity 24 hours after admission was reported in those patients who received hemoperfusion. However, inhibition of BuChE activity is not an important factor in the toxicity of OP, being probably a mere epiphenomenon. Therefore, use of changes in BuChE over 24 hours as the primary outcome in this study for determining the efficacy of hemoperfusion, renders the paper largely unhelpful in determining if this is a useful treatment strategy. The only basis on which hemoperfusion might be of benefit is if it enhances elimination of OP, and this was not measured. There is a relationship between the degree of BuChE inhibition by OP compounds and clinical severity, but it is inconsistent, and a causal relationship seems unlikely [3-9]. Different OPs have a different propensity to inhibit BuChE for the same degree of clinical severity and AChE inhibition [9]. Despite selecting patients with similar clinical severity who have taken different pesticides, the mean BuChE activity varied markedly. In patients with severe poisoning, the BuChE activity was 1211.4 ± 3066.3 mU/mL on admission, increasing to 2078.3 ± 2588.4 mU/mL at 24 hours. Although this increase was reported to be statistically significant (the statistical test is not stated nor is the magnitude of the P value), the data are obviously highly variable and skewed, and a nonparametric test should have been used. We also noted that different admission BuChE activities appear to have been reported in Table 1 and Table 2. However, even if this difference remained statistically significant, a benefit from hemoperfusion could only be assumed if there was a comparable control group indicating this was not simply an expected finding. Further, additional data From South Asian Clinical Toxicology Research Collaboration, Medical School, Australian National University, Australia; Department of Clinical Medicine, University of Colombo, Sri Lanka; and Department of Nephrology, Shanghai Tenth People’s Hospital of Tongji University, China.

Clinical Significance of the Dynamic Changes of Blood Cholinesterase on Patients with Acute Organophosphorus Poisoning

Blood and urine tests for early diagnosis of kidney injury in patients with acute organophosphorus pesticide poisoning

[Study on Monitoring and Clearing of Organophosphate in Blood in Organophosphate Poisoned Rats].

Observation on Clinical Effect of Hemodialysis and Hemoperfusion in the Treatment of Acute Severe Poisoning

[A Clinical Analysis of 104 Cases of Acute Pure and Mixed Organophosphate Poisoning].

Clinical Effect of Penehyclidine Hydrochloride, Atropine Plus Hemoperfusion On Patients with Acute Organophosphorus Pesticide Poisoning Combined with Respiratory Failure

The Roles of Catecholamine in Cardiac Injury after Severe Acute Dichlorvos Poisoning

Obidoxime in acute organophosphate poisoning: 1 – clinical effectiveness

Measure of Lipid and Lipoprotein of Patients with Acute Organophosphorus Pesticide Intoxication

The activity changes of myocardial enzymes of the patients with acute organophosphorus intoxication and their clinical meanings

Extracorporeal Blood Purification for Acute Organophosphorus Pesticide Poisoning.

[Comprehensive Analysis on Variation of Cardiac Enzyme and Troponin Induced by Acute Organophosphorous Poisoning].

Clinical study of continuous micropump infusion of atropine and pralidoxime chloride for treatment of severe acute organophosphorus insecticide poisoning

Correlation of Pseudocholinesterase Level with Clinical, Biochemical Parameters Including Cardiac Profile and the Outcome in Organophosphorus Poisoning

Clinical Application of Portable Organophosphorus Pesticide Fast Detector.

RETROSPECTIVE STUDY OF ORGANOPHOSPHORUS POISONING PATIENTS WITH REFERENCE TO CLINICAL PRESENTATION, SERUM CHOLINESTERASE LEVEL AND OUTCOME TO TREATMENT

Change of Liver Function of the Patients with Acute Organic Phosphorus Poisoning and Its Clinical Meaning

[Different Therapeutic Efficacy of Pralidoxime Chloride PAM-Cl on AChE Against Acute Toxicity of Methamidophos, Dichlorvos and Omethoate].

Changes of myocardial enzyme list and their clinical significance of patients with acute organic phosphorus intoxication

Utility of Automated Infrared Pupillometry in Assessing the Prolonged Course of Organophosphate Poisoning: A Case Report

Cholinesterase Aging Phenomenon Following Acute Ethoprophos Poisoning: A Case Report